[Gynecomastia in spironolactone therapy].
D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008297:Male; D013148:Spironolactone / Q000009:adverse effects*
D013148:Spironolactone
Gynäkomastie bei Spironolacton-Behandlung.